Login Contact Us
Oct 2018, Vol 6, Issue 4
Advanced Search
Title
Authors
Keyword
Poll
How do you find the scientific quality of the published articles on our web site?
Original Article
Letrozole Plus 2 Different Gonadotropins Regimens for Intrauterine Insemination in Polycystic Ovary Patients: A Randomized Clinical Trial
Mina Naghi Jafarabadi1, Seyedeh Houra Mosavi Vahed2, Malihe Afiat2, Zahra Ebrahimi3, Zahra Sadat Shiva4, Fedyeh Haghollahi1
1Vali-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
2Women’s Health Research Center, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Imam Hospital, Tehran University of Medical Sciences, Tehran, Iran
4Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

IJWHR 2018; 6: 420–424
DOI: 10.15296/ijwhr.2018.70
Viewed : 385 times
Downloaded : 175 times.

Keywords : HMG, Letrozole, Ovulation induction, Recombinant FSH, Polycystic ovary syndrome
Full Text(PDF) | Related Articles
Abstract
Objectives: The purpose of this study was to compare the effects of letrozole plus recombinant follicle stimulating hormone (R-FSH) and human menopausal gonadotropin (HMG) on ovarian stimulation in intrauterine insemination (IUI) cycle.

Materials and Methods: This randomized clinical trial was conducted on 130 women with polycystic ovary syndrome (PCOS) resistant to clomiphene and letrozole who were divided into A and B groups. Both groups received 5 mg of letrozole daily from the third to seventh day of the cycle and then group A (n = 59) received 75 units of HMG intramuscularly per day and group B received 75 units of R-FSH subcutaneously per day. Follicular maturation was triggered with 250 μg of recombinant human chorionic gonadotrophin (R-hCG) and IUI was performed 36 hours later. Main results under study were the number of matured follicles, endometrial thickness on the day of hCG injection, and the rate of chemical and clinical pregnancy.

Results: The 2 groups were not significantly different in demographic information. The rate of pregnancy was significantly higher in the letrozole + R-FSH group than in the letrozole+HMG group (20% and 5.8% respectively, P = 0.04). There was no significant difference between the 2 groups in the number of mature follicles (≤18 mm) and endometrial thickness at the time of hCG injection (P > 0.05).

Conclusions: Letrozole plus R-FSH is a recommended regimen for ovarian stimulation in PCOS patients.

Cite By, Google Scholar

Google Scholar

Articles by Naghi Jafarabadi M
Articles by Afiat M
Articles by Ebrahimi Z
Articles by Sadat Shiva Z
Articles by Haghollahi F

PubMed

Articles by Malihe Afiat
Articles by Zahra Ebrahimi
Articles by Zahra Sadat Shiva
Articles by Fedyeh Haghollahi

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics